Dr. Dhiman Basu, MD

Dr. Basu practices at Heritage Rheumatology and Arthritis Care in Colleyville, Texas.

Dr. Basu's NPI, 1336266964, was assigned on March 26, 2007. Dr. Basu graduated from Calcutta National Medical College in 1996. Dr. Basu's Texas license number on file is M7849.

Dr. Basu's primary practice is Heritage Rheumatology and Arthritis Care, at 5009 Heritage Ave, Colleyville, TX 76034-5913. The practice phone is (817) 590-0880.

Dr. Basu's primary practice is Heritage Rheumatology and Arthritis Care in Colleyville, Texas. The medical group on file is The American Arthritis And Rheumatology Associates (AARA). Dmand AI also links Dr. Basu to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Basu practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Basu's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Basu is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Basu's licenses on file in 2 states: Texas and Michigan.

Dmand AI lists arteritis, arthritis, gout, joint arthropathy, joint pain, lupus, muscle disease and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Basu treats.

CMS data shows 82,959 Medicare services from Dr. Basu across 16 procedure codes in 2024, for 275 Medicare patients. Medicare paid $896,190 for them. Every service was in an office.

CMS counts 275 Medicare patients who saw Dr. Basu in 2024. The largest group is 65 to 74, with 138 patients. 75% of them have arthritis, and 75% have high blood pressure. 5% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Basu's median patient age at 60, with 79% women.

In 2024, Dr. Basu wrote 4,344 Medicare Part D claims for 427 patients. 90% of them were for generic drugs. CMS names the drug for 3,900 of them, across 62 drugs with 11 or more claims each, at $1,014,418 in total drug cost. In 2023, CMS named 2,338 claims across 43 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Basu for performance year 2024, reported as part of a group. Dr. Basu accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 8 papers to Dr. Basu, published from 2009 to 2023. 2023 was the busiest year, with 2. The most frequent topics are Arthritis, Rheumatoid, Autoantigens and Black or African American. Dr. Basu's most frequent co-authors are Anca D. Askanase, MD, Mehdi Mirsaeidi, MD and John D. Reveille, MD.

Dmand AI links Dr. Basu to 12 clinical trials, 7 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Lupus Erythematosus, Systemic. GlaxoSmithKline sponsors the most, 4. Open Payments lists research payments to Dr. Basu that name 4 trials.

CMS Open Payments shows 6,078 general payments to Dr. Basu from 67 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 64% of the total. Amgen Inc. paid the most, $272,142. It also lists 6 research payments totaling $7,006 from 2019 to 2024, naming 4 clinical trials.

Dmand AI lists 2 awards for Dr. Basu, most recently CMS Stage 1 EHR in 2014.

Dr. Basu graduated from Calcutta National Medical College in 1996. Dr. Basu is a member of ACR.

Dr. Basu is in network with 23 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.